<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>1 </plain></SENT>
<SENT sid="1" pm="."><plain>The haemodynamic effects of intravenous nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> inhibitor, N-<z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (NOLA), were examined in four conscious non-restrained baboons (Papio hamadryas) </plain></SENT>
<SENT sid="2" pm="."><plain>Mean arterial pressure, (MAP), systemic vascular resistance (SVR) and cardiac output (CO) were measured at timed intervals up to 24 h after a bolus injection of NOLA </plain></SENT>
<SENT sid="3" pm="."><plain>2 </plain></SENT>
<SENT sid="4" pm="."><plain>N-<z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> <z:e sem="disease" ids="C0497247,C0020538" disease_type="Disease or Syndrome;Finding" abbrv="">increased blood pressure</z:e> in a dose-dependent manner up to 9.5 mg/kg </plain></SENT>
<SENT sid="5" pm="."><plain>Increases in blood pressure were accompanied by increases in SVR and decreases in CO, with a significant fall in heart rate </plain></SENT>
<SENT sid="6" pm="."><plain>3 </plain></SENT>
<SENT sid="7" pm="."><plain>One animal received 9.5 mg/kg NOLA and became unconscious, suggesting <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>4 </plain></SENT>
<SENT sid="9" pm="."><plain>Vascular effects of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> contribute significantly to the regulation of arterial blood pressure under physiological conditions in the baboon </plain></SENT>
</text></document>